Elfie Voices: Rethinking Health

Many symptoms women experience every day are labelled as normal.
But what if they are early warning signs of something more serious?
In this episode, Aya sits down with Dr. Malathi, a UK-trained physician with a background in internal medicine and endocrinology, to unpack how symptoms like fatigue, hormonal changes, and disrupted sleep can point to underlying metabolic conditions.
They explore why these signs are often dismissed, how delayed diagnosis impacts long term health, and why connecting the dots earlier could change outcomes entirely.
It is also the approach we take at Elfie, bringing different aspects of health together rather than treating them in silos, so people can better understand patterns, risks, and progress over time.

Follow us:

LinkedIn: ⁠⁠⁠⁠⁠Elfie⁠⁠⁠⁠⁠

Instagram: ⁠⁠⁠⁠⁠Elfie.en⁠⁠⁠⁠⁠

Facebook: ⁠⁠⁠⁠Elfie Global

What if your health tools knew you well enough to nudge you away from the cookie shop — not with a generic alert, but guidance built around your data, your goals, and your life?

Prof. Joe Kvedar has spent 40 years at the frontier of digital medicine. A Harvard Medical School dermatologist, former leader of a 60-person innovation center at Mass General, board chair of the American Telemedicine Association, co-chair of the AMA's digital medicine payment advisory group, and editor-in-chief of Nature's NPJ Digital Medicine — he's seen every wave of health tech and knows what actually works.

In this episode, Joe and Grace explore how multimodal AI is bringing us closer to truly personalized "N of 1" care, why the human bond between clinician and patient remains irreplaceable, the reality of clinician burnout and "pajama time," and what the massive supply-demand gap in healthcare means for insurers, pharma, and care delivery.

Released during Public Health Week 2026.

ElfieVoices is a podcast by Elfie — exploring the people and ideas shaping the future of digital health.

Follow us:

LinkedIn: ⁠⁠⁠⁠Elfie⁠⁠⁠⁠

Instagram: ⁠⁠⁠⁠Elfie.en⁠⁠⁠⁠

Facebook: ⁠⁠⁠Elfie Global

Obesity care is changing fast. New medications are reshaping what is possible, but they are only one part of the picture.

In this episode, Aya sits down with with Dra. Larissa Caballero, a physician specializing in cardiometabolic and preventive medicine, with a focus on obesity care and lifestyle medicine to unpack where obesity treatment is heading and why daily habits still play a defining role in long-term outcomes.

From shifting the perception of obesity as a lifestyle issue to recognizing it as a chronic condition, this conversation explores what modern, personalized care really looks like in practice.

Because lasting change does not happen in the clinic. It happens in the small, daily decisions that follow.

Follow us:

LinkedIn: ⁠⁠⁠Elfie⁠⁠⁠

Instagram: ⁠⁠⁠Elfie.en⁠⁠⁠

Facebook: ⁠⁠Elfie Global

What happens when you combine AI, messaging, and a system designed to scale healthcare access for entire populations?

You get a new model of care—one that isn’t just evolving, but leapfrogging traditional healthcare systems.

Across Africa, a powerful shift is underway:

• AI-driven pre-consultations that prepare and educate patients

• Messaging platforms like WhatsApp as the front door to care

• Digitally enabled healthcare workers extending reach and impact

All built for speed, simplicity, and scale—without the constraints that slow other markets down.

At the same time, millions of people remain undiagnosed with chronic conditions—creating one of the largest opportunities in global healthcare to improve outcomes and expand access.

For pharmaceutical and insurance leaders, the implications are clear:

• Growth will be unlocked through earlier diagnosis and sustained engagement

• Competitive advantage will come from ecosystems, not just products

• And the markets moving fastest today may define the global standard tomorrow

This isn’t catching up.It’s leapfrogging what came before.

Follow us:

LinkedIn: ⁠⁠⁠⁠Elfie⁠⁠⁠⁠

Instagram: ⁠⁠⁠⁠Elfie.en⁠⁠⁠⁠

Facebook: ⁠⁠⁠Elfie Global

In this episode, we unpack the shifting landscape of diabetes care and what it means for pharmaceutical companies and insurers.

From the rapid rise of GLP-1 therapies to the expanding role but questionable value of continuous glucose monitors (CGMs), innovation is reshaping how diabetes is treated, managed, and financed.

But the biggest question remains: what actually scales for the hundreds of millions of people living with diabetes worldwide?

Drawing on insights from the latest research and discussions at the Advanced Technologies and Treatments for Diabetes (ATTD) conference, the conversation explores how pharma–insurance partnerships, real-world evidence, and patient-centered behavioral strategies are redefining the future of chronic disease management.

For pharma executives, insurers, and healthcare leaders, this episode examines the economic and clinical forces driving the next playbook for diabetes at global scale.

Follow us:

LinkedIn: ⁠⁠⁠Elfie⁠⁠⁠

Instagram: ⁠⁠⁠Elfie.en⁠⁠⁠

Facebook: ⁠⁠Elfie Global

This episode dives into how simple reflective check-ins on sleep, mood, and energy can transform everyday data into powerful early-warning signals, helping you spot stress before it spirals.​

Joining us is Vivian, Elfie’s own mindfulness and meditation instructor, certified nutritionist, and health content writer, who brings a unique blend of neuroscience, behavior science, and practical coaching to the conversation.

Vivian is passionate about turning evidence-based insights into accessible tools, empowering people to upgrade their well-being through mindful routines, smarter tracking, and science-backed education.

Follow us:

LinkedIn: ⁠⁠Elfie⁠⁠

Instagram: ⁠⁠Elfie.en⁠⁠

Facebook: ⁠Elfie Global

AI is flooding into healthcare, but where is it actually making a difference? In this episode, Ofir Ejnes, Jean-Francois Legourd and Grace McNamara explore the surge of clinical AI tools, from AI scribes to the deeper challenges of trust, regulation, and data quality. The discussion moves beyond hype to examine what it will take for AI to genuinely improve care, workflows, and patient outcomes.

Follow us:

LinkedIn: ⁠⁠⁠⁠Elfie⁠⁠⁠⁠

Instagram: ⁠⁠⁠⁠Elfie.en⁠⁠⁠⁠

Facebook: ⁠⁠⁠Elfie Global

Health apps aren’t dead. But many are failing to deliver real health impact. In this episode, we unpack why the digital health ecosystem has become so fragmented and why AI has pushed the industry into a “wild west” phase of rapid innovation without clear structure.
Ofir Ejnes, Jean-François Legourd, and Grace McNamara explore what it will take to move beyond thousands of disconnected apps towards real health infrastructure. From building patient motivation and trusted AI systems to structuring health data and forging partnerships with pharma, insurers and public health systems, the conversation looks at how digital health can finally deliver meaningful outcomes.

Follow us:

LinkedIn: ⁠⁠⁠⁠Elfie⁠⁠⁠⁠

Instagram: ⁠⁠⁠⁠Elfie.en⁠⁠⁠⁠

Facebook: ⁠⁠⁠Elfie Global

High blood pressure is a silent killer. Patients don’t feel it, and that’s exactly what makes it dangerous.

In this episode, we meet Erica, a hypertensive patient from Brazil whose diagnosis came completely out of the blue. She was eating well, exercising, doing everything “right.” Then one day, out of casual curiosity, she checked her blood pressure, and the numbers were alarmingly high.

No symptoms. No warning. Just data.

Erica’s story is a powerful reminder that when it comes to hypertension, waiting to feel unwell can mean waiting too long. We explore what it takes to move from reactive care to proactive awareness, the discipline of monitoring even when life feels fine, and why consistent measurement can be an act of prevention.

This conversation dives beyond clinical facts into real life. Why don’t patients measure unless they feel sick? Why does prevention still seem optional? And what does personal responsibility mean in a world built around treatment rather than early detection?

A prescription only works if it’s taken. Yet in cardiovascular care, consistency is often the weakest link. In this episode, cardiologist Dr Mario Fritsch, one of Brazil’s leading voices in heart health, Professor of Internal Medicine, Director of the Biomedical Center at UERJ and former President of the Brazilian Society of Hypertension, takes us inside the adherence crisis shaping cardiovascular care. Drawing on decades of clinical and academic experience, he shares what really happens when heart medication is missed, delayed or quietly stopped.

We unpack the real reasons patients fall off track, from psychology to everyday pressure, and explore what actually changes behaviour. From stronger doctor–patient relationships to smarter digital tools that support tracking, reminders and accountability between visits, this is a conversation about moving beyond blame and building systems that make consistency easier, and heart care safer.

Follow us:

LinkedIn: ⁠⁠⁠Elfie⁠⁠⁠

Instagram: ⁠⁠⁠Elfie.en⁠⁠⁠

Facebook: ⁠⁠Elfie Global